Warby Parker (WRBY) Income from Continuing Operations (2020 - 2026)
Warby Parker's (WRBY) quarterly Income from Continuing Operations came in at 3177000.0 in Q1 2026, down 8.5% YoY from 3472000.0 in Q1 2025, and up 153.39% on a QoQ basis from 5951000.0 in Q4 2025.
Warby Parker (WRBY) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Income from Continuing Operations data on file, last reported at 3177000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 8.5% year-over-year to 3177000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1348000.0 (up 109.45% YoY) and the FY2025 annual result came in at 1643000.0, up 108.05% from the prior year.
- Income from Continuing Operations improved to 3177000.0 in Q1 2026, from 5951000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 5874000.0 in Q3 2025 to a low of 34133000.0 in Q1 2022.
- A 5-year average of 11128529.41 and a median of 6902000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 1217.28% — and 2025, when it soared 244.25%.
- Tracing WRBY's Income from Continuing Operations over 5 years: stood at 20251000.0 in 2022, then climbed by 5.95% to 19047000.0 in 2023, then soared by 63.76% to 6902000.0 in 2024, then climbed by 13.78% to 5951000.0 in 2025, then soared by 153.39% to 3177000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3177000.0 (Q1 2026), 5951000.0 (Q4 2025), and 5874000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.64 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | -5.95 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | -1.75 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | -6.90 Mn |
| Sep 30, 2024 | -4.07 Mn |
| Jun 30, 2024 | -6.76 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -19.05 Mn |
| Sep 30, 2023 | -17.41 Mn |
| Jun 30, 2023 | -15.93 Mn |
| Mar 31, 2023 | -10.81 Mn |
| Dec 31, 2022 | -20.25 Mn |
| Sep 30, 2022 | -23.84 Mn |
| Jun 30, 2022 | -32.17 Mn |
| Mar 31, 2022 | -34.13 Mn |
| Dec 31, 2021 | -45.90 Mn |
| Sep 30, 2021 | -91.07 Mn |